Luciferase Reporter Cell Line - SK-HEP-1

SK-HEP-1 cells are a human liver endothelial adenocarcinoma-derived cell line commonly used in cancer biology and hepatobiliary research. They are characterized by epithelial-like morphology, moderate proliferative capacity, and the ability to support studies of tumor-associated endothelial behavior and angiogenesis-related signaling. As a tumor-derived model, SK-HEP-1 cells retain key features relevant to hepatic malignancies, including responsiveness to growth factors and dysregulation of signaling pathways involved in cell migration, invasion, and vascular remodeling. The Luciferase Reporter Cell Line – SK-HEP-1 is constructed by introducing a stable luciferase reporter cassette driven by pathway-responsive promoters or transcription factor binding elements into the parental SK-HEP-1 background, enabling real-time and quantitative assessment of transcriptional regulation while preserving the biological characteristics of the original cell line.

The Luciferase Reporter Cell Line – SK-HEP-1 is widely used in liver cancer research, angiogenesis studies, and drug discovery programs targeting tumor microenvironment regulation. It is particularly valuable for investigating signaling pathways such as VEGF/VEGFR, NF-κB, MAPK/ERK, and hypoxia-responsive signaling (HIF-related pathways), which play critical roles in tumor progression and vascular development. The luciferase reporter system provides a sensitive and reproducible readout for monitoring pathway activation or inhibition following treatment with small molecules, biologics, or genetic perturbations. This model is frequently applied in high-throughput screening for anti-angiogenic and anti-tumor compounds, as well as in mechanistic studies of endothelial-tumor interactions. Its stability, sensitivity, and compatibility with quantitative assays make it a reliable platform for both basic research and preclinical evaluation of therapeutic candidates in hepatocellular and vascular-associated malignancies.